Pharmaceutical Potential If and when Big Pharma gets involved, the potential for $100-a-share stocks rises and profits soar. There are numerous Canadian companies taking part in “drug trials� of cannabis products. The potential to become the new era of Big Pharma needs to overcome a lack of lobbying power from the cannabis industry. That could change, leaving the door open to the same greed and expansion in cannabis as happened to large American medical pharma stocks that trade at big dollars.
The Political Landscape There are two obstacles that face American companies. There is the obvious flaw that the stuff is still classified as a Schedule I drug. The second? There are few banking options open to securing a safe transaction landscape. Up in the Great White North, Canadian companies recently came under scrutiny from the Canadian Securities Administrators (CSA) when reviewing the policy about cannabis companies listed on Canadian exchanges that have interests in the states. This came in early January after U.S. Attorney General Jeff Sessions spewed his negative rhetoric about the evils of cannabis that sent cold shivers on both sides of the border when he rescinded the Cole Memo. The uncertainty left companies with U.S. ties faced with being delisted from Canadian exchanges. CSA released new guidance on the issue, which expanded the amount of disclosure U.S.-exposed cannabis companies need to give, but left everything else largely unchanged. Let the games continue. If the United States Senate or House ever let a bill reach the floor and the White House, the floodgates could open. Now there is fear for investors who are afraid of losing everything if the Justice Department were to mount a crackdown on all cannabis-friendly states. With many analysts touting that cannabis companies are the fastest-growing industry and that they show unlimited growth for future jobs and tax base contributions, making cannabis illegal would blow a lot of revenue and send the black market business soaring.
The Canadian Invasion
Canadian cannabis and CBD stocks can be found primarily on three exchanges as well as being sold over the counter (OTC). They can change exchanges when acquisitions occur. Some have had trading suspended for brief periods while expansions and acquisitions were announced. Symbols are often changing as big fish often eat little fish.
march | elevatenv.com 23